KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gentex (GNTX) Research & Development (2016 - 2025)

Historic Research & Development for Gentex (GNTX) over the last 17 years, with Q3 2025 value amounting to $52.6 million.

  • Gentex's Research & Development rose 914.18% to $52.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $197.1 million, marking a year-over-year increase of 1201.9%. This contributed to the annual value of $181.5 million for FY2024, which is 1756.65% up from last year.
  • Gentex's Research & Development amounted to $52.6 million in Q3 2025, which was up 914.18% from $51.5 million recorded in Q2 2025.
  • Gentex's 5-year Research & Development high stood at $52.6 million for Q3 2025, and its period low was $27.7 million during Q1 2021.
  • Moreover, its 5-year median value for Research & Development was $38.0 million (2023), whereas its average is $38.8 million.
  • As far as peak fluctuations go, Gentex's Research & Development plummeted by 662.95% in 2021, and later soared by 2172.42% in 2024.
  • Gentex's Research & Development (Quarter) stood at $31.3 million in 2021, then grew by 11.61% to $34.9 million in 2022, then grew by 18.89% to $41.5 million in 2023, then rose by 13.31% to $47.1 million in 2024, then rose by 11.84% to $52.6 million in 2025.
  • Its Research & Development was $52.6 million in Q3 2025, compared to $51.5 million in Q2 2025 and $45.9 million in Q1 2025.